Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 140.28-4.4613.37610.65-249.43

What is the latest EBIT Growth ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Growth ratio of SOTAC PHARMACEUTICALS is 140.28 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025140.28
Mar2024-4.46
Mar202313.37
Mar2022610.65
Mar2021-249.43

How is EBIT Growth of SOTAC PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 140.28
Positive
Mar2024 -4.46
Negative
Mar2023 13.37
-97.81
Mar2022 610.65
Positive
Mar2021 -249.43 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹123.2 Cr 4.7% 0.9% -11.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,677.0 Cr -2.4% 6.4% 7% Stock Analytics
DIVIS LABORATORIES ₹180,458.0 Cr -0.9% 5% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹153,685.0 Cr 1.6% 7.6% 38.5% Stock Analytics
CIPLA ₹114,562.0 Cr 1.2% 7.7% -3.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,095.0 Cr 0.1% -1.2% 8.7% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

4.7%

0.9%

-11.2%

SENSEX

0.7%

-1%

-7%


You may also like the below Video Courses